Medical Bulletin 28/November/2022

Published On 2022-11-28 10:57 GMT   |   Update On 2022-11-28 10:57 GMT

Here are the top medical news for the day:Fluoxetine benefits patients of refractory monosymptomatic nocturnal enuresisNocturnal enuresis is involuntary urination that happens at night while sleeping, after the age when a person should be able to control his or her bladder. Most of us think of bedwetting as something that happens with little kids.For children and adolescents with...

Login or Register to read the full article
Here are the top medical news for the day:

Fluoxetine benefits patients of refractory monosymptomatic nocturnal enuresis

Nocturnal enuresis is involuntary urination that happens at night while sleeping, after the age when a person should be able to control his or her bladder. Most of us think of bedwetting as something that happens with little kids.

For children and adolescents with refractory primary monosymptomatic nocturnal enuresis (PMNE), fluoxetine therapy, a selective serotonin reuptake inhibitor, is a safe therapeutic option that produces an initial positive response. A study that appeared in the Journal of Urology found that the response rate does, however, gradually decline with time.

For more details, check out the link given below:

Fluoxetine benefits patients of refractory monosymptomatic nocturnal enuresis


High levels of HCG after single embryo transfer tied to pre eclampsia risk

Human chorionic gonadotrophin can be detected in the maternal serum, confirming early pregnancy. The success of implantation is measured by early concentration after IVF and embryo transfer.

A study published in the Reproductive Biomedicine Online is the first known report highlighting the link between high HCG (Human chorionic gonadotrophin) levels after Single Embryo Transfer (SET) and the development of adverse pregnancy outcomes.

For more details, check out the link given below:

High Levels Of HCG After Single Embryo Transfer Tied To Pre-Eclampsia Risk


Fasting blood sugar variability linked with cancer risk in T2DM patients

Studies have reported that fasting blood sugar level is independently associated with the risk of cancer onset but in accordance to a recent study published in the Journal of Diabetes which has found that long-term changes in fasting blood sugar are positively associated with the risk of cancer in type 2 diabetes patients.

The researchers collected data from 46 761 patients with T2DM aged between 20-80 years. To describe fasting blood sugar variability, four indicators were adopted, including coefficient of variation (CV), average real variability (ARV), standard deviation (SD), and variation independent of the mean (VIM). The association between long-term fasting blood sugar variability and cancer risk was investigated. The interactive effect of FBG variability was determined with hypertension and fasting blood sugar -mean with hypertension on the risk of cancer, respectively.

For more details, check out the link given below:

Fasting Blood Sugar Variability Linked With Cancer Risk In Patients With Type 2 Diabetes

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Medical Bulletin 07/ May/ 2024
Medical Bulletin 06/ May/2024
Medical Bulletin 04/ May/ 2024
Medical Bulletin 03/ May/ 2024